Skip to main content

Table 1 Characteristics of the study population and follow up

From: Totally implantable venous access devices: retrospective analysis of different insertion techniques and predictors of complications in 796 devices implanted in a single institution

Characteristic Total population 796 pts
Age (years, median/range) 61 (21–87)
Gender (F/M) 432/364
Body Mass Index (kg/m2, median, range IQR) 24.23 (21.9-27.18)
Follow up (weeks, median, range IQR) 35.14 (23–55.4)
Follow up completed (n° pts/total pts) 535/796
Length of use (weeks, median, range IQR) 22.71 (10.1-41.9)
Time of in-situ permanence (weeks, median, range IQR) 33.71 (15.71-57)
Pancreatic cancer (n° pts) 20
Colon/rectal cancer 218
Gastric cancer 67
Oesophageal cancer 102
Lymphoma 29
Breast cancer 127
Brain cancer 14
Head and neck cancer 33
Sarcoma 48
Liver cancer 15
Lung cancer 36
Ovarian cancer 38
Melanoma 13
Urothelial cancer 6
Teratoma 5
Other miscellaneous 25
White blood cells count (cells ×109/L, median, range IQR) 6 (1.98-8.77)
Hb (g/L, median, range IQR) 12 (10–13)
Platelets (cells × 109/L, median, range IQR) 276 (223–341.5)
PT (%, prothrombin time, median, range IQR) 88 (75–100)
PTT (sec, partial thromboplastin time, median, range IQR) 28 (26–30)
INR (international normalized ratio, median, range IQR) 1,00 (0.5-1.12)
\